WeedMD, on Sedar March 8, 2021 page 14---------Other Planned Expenditures------------ In addition to the amounts that will be allocated to achieve the milestones set out above, the Company has $ 12.7 million of commitments and approximately payments (excluding lease obligations which are $ 1.72 million for 2021) that come due in 2021 ($ 11.9 million in 2022). The Company believes such commitments can be serviced with working capital generated by the business of the Company over such time periods. The Company does not anticipate having to use any of the net proceeds towards the satisfaction of such commitments. As at January 31, 2021 the Company had a cash balance of approximately $ 18 million and working capital of approximately $ 62 million, comprised of cash (approximately $ 18 million), inventory and biological assets (approximately $ 48 million), receivables ($ 9 million) and other assets, offset by approximately $ 15 million in current liabilities. The Company expects it will be able to continue operations indefinitely using its currently available resources and the net proceeds of the Offering.